tiletamine hydrochloride has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, YJ; Cheng, YJ; Hou, MF; Hung, AC; Tyan, YC; Wu, YC; Yuan, SS | 1 |
| Bradshaw, TD; Carmichael, J; Martin, SG; Mukherjee, A; Stevens, MF; Westwell, AD | 1 |
2 other study(ies) available for tiletamine hydrochloride and Angiogenesis, Pathologic
| Article | Year |
|---|---|
The synthetic flavonoid WYC02-9 inhibits cervical cancer cell migration/invasion and angiogenesis via MAPK14 signaling.
Topics: Animals; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Movement; Cyclohexanones; Female; Flavones; Flavonoids; HeLa Cells; Humans; MAP Kinase Signaling System; Mice; Mice, Nude; Mitogen-Activated Protein Kinase 14; Neovascularization, Pathologic; Uterine Cervical Neoplasms; Xenograft Model Antitumor Assays; Zebrafish | 2013 |
Cytotoxic and antiangiogenic activity of AW464 (NSC 706704), a novel thioredoxin inhibitor: an in vitro study.
Topics: Antineoplastic Agents; Benzothiazoles; Breast Neoplasms; Cell Line, Tumor; Colonic Neoplasms; Cyclohexanones; Endothelial Cells; Enzyme-Linked Immunosorbent Assay; Fibroblast Growth Factor 2; Fibroblasts; Humans; Hypoxia; In Vitro Techniques; Neovascularization, Pathologic; Thiazoles | 2005 |